Genetic Signatures Ltd ABN 30 095 913 205 7 Eliza Street, Newtown NSW 2042 Telephone + 61 (2) 9870 7580 1 ASX Announcement 16 October 2026 RESPONSE TO MEDIA SPECULATION & BCAL DIAGNOSTICS LETTER TO GSS SHAREHOLDERS • Genetic Signatures Limited (ASX: GSS) (GSS) calls...
GSS: Response to Media Speculation & BCAL letter to GSS
Filed with ASX · · 3 pages · English
Release
BCAL Diagnostics Limited on 6ix
In the deck
Story so far
Earlier from BCAL Diagnostics
- BREASTESTplus 2 clinically validated
- BCAL Introduces Avantect Multi-Cancer Early Detection Test
- Appendix 4E and Annual Report to shareholders
- BCAL Takes Interest in Genetic Signatures to 18.46%
- BCAL Secures Funding for FY2027 Update
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics